
Sign up to save your podcasts
Or


Private equity keeps funding well-capitalized startups that promise a fully automated future, and you are left wondering whether your medical billing company can survive against an AI native RCM competitor with nine figures in the bank.
Sean McSweeney challenges the fear and hype around AI native RCM platforms. He separates the investor pitch from operational reality and draws on his own early mistakes entering medical billing to explain why a company built from scratch may not be the unstoppable force it appears to be.
What You'll Learn:
Competition from AI native RCM companies is real, but this episode makes the case that you do not need to panic about being wiped out overnight.
From the publisher's feed

199 Listeners

10,780 Listeners